Clinical trial
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
NCT00482794 · Duke University, Other · Recruiting
Key facts
| NCT number | NCT00482794 |
|---|---|
| Title | Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome |
| Official title | Genetics of Antiphospholipid Antibody Syndrome |
| Acronym | APS |
| Lead sponsor | Duke University, Other |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Antiphospholipid Syndrome |
| Enrollment | 2,800 |
| Start date | Jun 1, 2006 |
| Primary completion | Mar 1, 2028 |
| Completion | Mar 1, 2028 |
| First posted | Jun 5, 2007 |
| Last update posted | Mar 19, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: